Trial intelligence / Profile preview

Liraglutide effects on MMC and food intake in healthy volunteers

NCT04008290Phase 4Unknown

Sponsor
UZ Leuven
Start
Apr 2020
Primary completion
Apr 2021
Modality
Peptides
01

Overview

A Phase 4 trial of liraglutide in obesity, sponsored by UZ Leuven. Status: unknown.

02

Drugs

03

Conditions

obesity

Beyond the preview

Go deeper on NCT04008290.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04008290.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call